title: Metastasis awakening: the challenges of targeting minimal residual cancer.
authors: Fraunhofer-Institut für Toxikologie und Experimentelle Medizin, Project Group Personalized Tumor Therapy, Regensburg, Germany.
authors: Bernhard
authors: B
authors: Polzer
authors: Christoph A
authors: CA
authors: Klein
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D019008:Drug Resistance, Neoplasm; D006801:Humans; D058990:Molecular Targeted Therapy; D009362:Neoplasm Metastasis / Q000188:drug therapy / Q000473:pathology*; D018365:Neoplasm, Residual / Q000188:drug therapy* / Q000473:pathology*; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D009360:Neoplastic Cells, Circulating / Q000187:drug effects* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents